Patents Assigned to Toltec Pharmaceuticals, LLC
  • Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
    Patent number: 8956663
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: February 17, 2015
    Assignee: Toltec Pharmaceuticals, LLC
    Inventors: Suzanne Gordon, Dawn Flynn
  • Compositions and Methods for Treating Vaginal Infections and Pathogenic Vaginal Biofilms
    Publication number: 20130101678
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Application
    Filed: December 10, 2012
    Publication date: April 25, 2013
    Applicant: TOLTEC PHARMACEUTICALS, LLC
    Inventor: Toltec Pharmaceuticals, LLC
  • Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
    Patent number: 8349368
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: January 8, 2013
    Assignee: Toltec Pharmaceuticals, LLC
    Inventors: Suzanne Gordon, Dawn Flynn